Although this seems contradictory to our findings, we do not necessarily show activation of the TGF-β pathway, but instead a dysregulation, which might also explain the different findings described above on TGF-β signaling pathway involvement in AAA versus TAA. The gene discussed is TGFB1; the disease is triple-A syndrome.